{"public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "source": "Twitter Web App", "possibly_sensitive": false, "entities": {"hashtags": [{"start": 96, "end": 104, "tag": "COVAXIN"}], "mentions": [{"start": 0, "end": 8, "username": "gmanews", "id": "39453212"}, {"start": 9, "end": 21, "username": "shailagarde", "id": "128226120"}], "annotations": [{"start": 49, "end": 53, "probability": 0.979, "type": "Place", "normalized_text": "India"}], "urls": [{"start": 107, "end": 130, "url": "https://t.co/DTNXlFanH3", "expanded_url": "https://www.dailywibes.com/2020/06/30/covaxin-all-we-know-about-indias-first-under-trial-coronavirus-vaccine/", "display_url": "dailywibes.com/2020/06/30/cov\u2026"}]}, "created_at": "2020-06-30T09:39:10.000Z", "id": "1277899469216940032", "text": "@gmanews @shailagarde COVAXIN: All we know about India's first under trial coronavirus vaccine\n\n#COVAXIN \n\nhttps://t.co/DTNXlFanH3", "lang": "en", "in_reply_to_user_id": "39453212", "reply_settings": "everyone", "referenced_tweets": [{"type": "replied_to", "id": "1277886083104153601"}], "author_id": "1270252428672278528", "conversation_id": "1277886083104153601", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}]}